Drug Discovery & Development Standardizing metabolomics advances biomarker discoveryDiscover how prioritizing reproducibility and method validation can empower researchers to unlock the full potential of metabolomics in advancing biomarker discovery and drug development
Clinical Diagnostics Trials and tribulations in the quest for QC perfection with patient-like controls May 28, 2025
Life Sciences Generating high-quality mRNA-LNP complexes for in vivo delivery: Strategies and methods May 29, 2025
Life Sciences Screening of immune engager compounds using CRC patient-derived organoids (or “mini-organs”) and immune T cells subsets
Life Sciences High-throughput automation in next-generation sequencing for the detection of minimum residual disease in liquid biopsies
Food and Beverage BUCHI acquires Si-Ware Systems’ NeoSpectra platform to establish a fully integrated quality assurance ecosystem based on NIR
Clinical Diagnostics QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software
Clinical Diagnostics Revvity’s EUROIMMUN unveils new fully automated instrument for specialty testing
Drug discovery > Clinical Development N4 Pharma announces success in positive in vivo results from first Nuvec study for IBD dual-loaded with siRNA and mRNA
Life Sciences Biotium expands Cheetah Taq portfolio with new formulations for fast cycling PCR and proximity extension assays